Interview 27 Feb 2019
How to Make Cancer Drug Resistance Futile
For many solid tumors, treatments undergo a cycle: the drugs initially work well, the tumor shrinks, but then becomes resistant again. Stefanie Flückiger-Mangual, CEO of the Swiss biotech Tolremo, believes that this cycle can be stopped. Solid tumors often act like a recurring villain in a TV series. Whatever drug you throw at them, however […]